In what circumstance would you consider stopping tisotumab-vedotin after a complete response for a patient with recurrent/persistent cervical cancer?

If a patient has a complete response to tisotumab vedotin for recurrent cervical cancer, what would you recommend?

• Continue tisotumab until toxicity
• Discontinue tisotumab
• Other